ALAMEDA, California – 23 May 2018 – AllCells, a leading provider of healthy hematological/immunological tissue, primary cell-based products, and CliniCells®️ clinical-grade products for further manufacturing of allogeneic cell therapies, will be attending the 2018 Biotechnology Industry Organization (BIO) International Convention One-on-One Partnering™ program to be held in Boston, MA, 4-7 June 2018. Wayne Vaz – VP, Corporate & Global Business Development, and Hassan Saleem, GM & Business Development, Quincy, MA Leukolab Operations, will be available to meet at the Boston Convention and Exhibition Center (BCEC) to discuss the company’s capabilities, strategic partnership and collaboration interests.
Meetings can be pre-scheduled before arriving in Boston and hosted in the BIO Business Forum. BIO participants interested in learning more about AllCells or scheduling meetings to discuss partnering opportunities should login to BIO’s One-on-One Partnering™ program page. Individuals not directly participating in the Business Forum who wish to meet AllCells company representatives may contact Wayne Vaz or Hassan Saleem to make separate arrangements. BIO One-on-One Partnering is a trademark of the Biotechnology Industry Organization.
About AllCells, LLC
AllCells is a biotechnology company dedicated to providing researchers and biomanufacturing organizations with high quality primary cells that enable drug discovery, preclinical development, and manufacturing of cell therapies. Leveraging its expertise in hematology and immunology cell isolations together with on-site hematologic tissue clinical collection operations, AllCells maintains a large repository of donor profiles that can be qualified for various biomedical applications. Freshly collected tissue is immediately processed in contiguous manufacturing facilities to produce purified cell types having unparalleled quality and consistency. Cells are shipped worldwide, or fresh cells can be immediately utilized in fee-for-service cell-based assays (AllCellutions™). For more information, please visit www.allcells.com.